BIP Q3 2025 Earnings Call Transcript

Blackbaud delivered 2025 organic revenue growth of 5.5% to $1.128 billion, adjusted EBITDA of $405 million (+8%), and non-GAAP EPS of $4.45 (+12%), while free cash flow reached $208 million and leverage fell to 2.5x. Management guided 2026 organic revenue to $1.173 billion-$1.179 billion, adjusted EBITDA to $430 million-$438 million, and EPS to $5.15-$5.25, while highlighting AI-driven product launches and plans to return at least 50% of cumulative 2026-2030 free cash flow to share repurchases. The call emphasized longer contract durations, margin expansion, and new agentic AI products as potential upside not fully reflected in guidance.

Analysis

BLKB is signaling a second derivative story: the market is still underwriting a mature vertical SaaS compounder, while management is attempting to re-rate the name as an AI-enabled workflow platform with embedded distribution. The important nuance is that the first monetizable agent is likely less about near-term ARR scale and more about proof that proprietary data + workflow lock-in can support premium attach rates without triggering customer pushback. If adoption is real, the company can expand monetization in three layers: subscription uplift, higher transactional volume, and lower churn via longer contracts.

The bigger earnings surprise risk is on margins, not revenue. The combination of offshoring, data-center rationalization, and internal AI automation creates a credible path to 40%+ EBITDA margins, but the timing is lumpy and depends on execution across support, engineering, and renewals. That means the stock may trade better on quarterly margin beats than on headline growth, especially since the back-half weighting increases the chance of softer first-half sentiment and multiple compression before the operating leverage shows up.

Consensus is probably underestimating how much buybacks can dominate per-share optics if free cash flow inflects as guided. With leverage already trending down, the company has room to keep shrinking the float while still funding AI/product investment, which can make EPS growth structurally outpace revenue growth for several years. The contrarian risk is that the AI narrative is real but not immediately monetizable, and if renewal cohorts slip even modestly, the market may treat the product-launch story as optionality rather than a re-rating catalyst.

Key Decisions for Investors

• Long BLKB on pullbacks into the next 2-6 weeks; thesis is that the setup supports a multiple grind higher as buybacks and deleveraging offset conservative growth guide. Risk/reward is attractive if the stock can re-rate on 2026 FCF visibility and AI attach-rate evidence.
• Buy BLKB call spreads 3-6 months out rather than outright equity if you want exposure to the AI-product upside with defined downside; structure around a post-earnings or product-catalyst window where back-half guidance could be revised up.
• Pair trade: long BLKB / short a slower-growing vertical SaaS peer with weaker FCF conversion and less capital return. The relative trade should work if the market rewards per-share compounding and punishes names without a clear buyback flywheel.
• Avoid chasing BLKB after sharp rallies; wait for any first-half revenue deceleration or growth-stock de-risking to establish the position. The cleanest entry is when investors fade the guidance conservatism before Q3/Q4 catalysts arrive.
• Monitor for evidence that the Development Agent is driving net-new logos by mid-2026; if attach rates stay limited to existing customers, trim exposure because the market will likely cap the AI multiple expansion premium.